Globe Life (NYSE:GL) Issues Earnings Results

Globe Life (NYSE:GL) issued its quarterly earnings results on Wednesday. The company reported $3.14 EPS for the quarter, beating analysts’ consensus estimates of $3.12 by $0.02, Zacks reports. Globe Life had a return on equity of 22.91% and a net margin of 19.04%. Globe Life updated its FY 2025 guidance to 13.450-14.050 EPS.

Globe Life Price Performance

Shares of GL traded up $0.52 during mid-day trading on Wednesday, hitting $122.93. The company’s stock had a trading volume of 587,098 shares, compared to its average volume of 551,996. Globe Life has a fifty-two week low of $38.95 and a fifty-two week high of $132.00. The stock has a market capitalization of $10.32 billion, a price-to-earnings ratio of 10.40 and a beta of 0.81. The firm has a 50-day moving average price of $112.56 and a 200 day moving average price of $106.41. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.05 and a quick ratio of 0.05.

Globe Life Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Monday, January 6th were given a dividend of $0.24 per share. The ex-dividend date of this dividend was Monday, January 6th. This represents a $0.96 annualized dividend and a dividend yield of 0.78%. Globe Life’s dividend payout ratio (DPR) is 8.12%.

Wall Street Analysts Forecast Growth

A number of analysts recently issued reports on the stock. Raymond James lifted their price target on shares of Globe Life from $160.00 to $188.00 and gave the stock a “strong-buy” rating in a research note on Tuesday, October 15th. Piper Sandler increased their price target on shares of Globe Life from $118.00 to $130.00 and gave the stock an “overweight” rating in a research report on Friday, October 25th. TD Cowen initiated coverage on Globe Life in a report on Wednesday, October 9th. They issued a “buy” rating and a $150.00 price objective for the company. Wells Fargo & Company raised their price target on shares of Globe Life from $108.00 to $117.00 and gave the stock an “overweight” rating in a research report on Thursday, October 10th. Finally, Jefferies Financial Group upped their price objective on Globe Life from $107.00 to $114.00 and gave the stock a “hold” rating in a research note on Tuesday, December 10th. Five analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $132.18.

Insider Buying and Selling

In other Globe Life news, Director Mark A. Blinn sold 3,000 shares of the firm’s stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $113.23, for a total value of $339,690.00. Following the completion of the transaction, the director now directly owns 5,122 shares in the company, valued at $579,964.06. This trade represents a 36.94 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, CEO Frank M. Svoboda sold 14,340 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The shares were sold at an average price of $108.80, for a total transaction of $1,560,192.00. Following the sale, the chief executive officer now owns 16,396 shares in the company, valued at $1,783,884.80. This represents a 46.66 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 39,788 shares of company stock worth $4,429,779. Corporate insiders own 1.51% of the company’s stock.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.